ACHE and Alzheimer disease: Four of the six drugs currently approved by the U.S. Food and Drug Administration (FDA) for treating AD, namely, tacrine, donepezil, rivastigmine, and galantamine increase the amount of acetylcholine neurotransmitter in the brain by inhibiting the action of AChE [8,9].